|
⚲
|
| Keyboard |
| Harsch Mutya
✚
|
|
|---|---|
| CIK # | 0001727809 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727809] | |
| 4 | [0001727809] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harsch Mutya | |
| VYNE Therapeutics Inc | |
| Satsuma Pharmaceuticals Inc | |
| Foamix Pharmaceuticals Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2025-12-31 | Tax withheld | 3,579 | $0.58 | 2,076 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2025-09-30 | Tax withheld | 3,581 | $0.34 | 1,218 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2025-06-30 | Tax withheld | 3,581 | $1.65 | 5,909 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2025-06-02 | Grant | 1,145 | $0.81 | 927 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2025-03-31 | Tax withheld | 8,828 | $1.58 | 13,948 |
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2025-01-21 | Grant | 230,000 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-12-31 | Tax withheld | 4,697 | $3.35 | 15,735 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-09-30 | Tax withheld | 105 | $1.88 | 197 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-07-01 | Tax withheld | 143 | $1.92 | 275 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-04-01 | Tax withheld | 161 | $3.08 | 496 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-01-02 | Tax withheld | 161 | $2.28 | 367 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2024-01-01 | Grant | 62,500 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2024-01-01 | Grant | 62,500 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2023-12-13 | Grant | 62,500 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
|
2023-12-13 | Grant | 62,500 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2023-10-02 | Tax withheld | 1,154 | $3.83 | 4,420 |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2023-06-30 | Tax withheld | 157 | $4.10 | 644 |
|
Satsuma Pharmaceuticals Inc STSA
Stock Option (right to buy) · derivative
|
2023-06-08 | Disposed to issuer | 40,000 | $0.00 | |
|
Satsuma Pharmaceuticals Inc STSA
Stock Option (right to buy) · derivative
|
2023-06-08 | Disposed to issuer | 30,000 | $0.00 | |
|
VYNE Therapeutics Inc VYNE
Common Stock
|
2023-05-31 | Grant | 3,664 | $3.46 | 12,677 |
| showing 20 of 70 most recent transactions | |||||